Morita A, Strober B, Burden AD, Choon SE, et al. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. Lancet 2023 Sep 19:S0140-6736(23)01378-8. doi: 10.1016/S0140-6736(23)01378.
PMID: 37738999